Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;15(1):29–34. doi: 10.1111/j.1750-3639.2005.tb00097.x

Profound Cardiac Sympathetic Denervation Occurs in Parkinson Disease

Takeshi Amino 1,2,5, Satoshi Orimo 1,2,✉, Yoshinori Itoh 3, Atsushi Takahashi 4, Toshiki Uchihara 2, Hidehiro Mizusawa 5
PMCID: PMC8095848  PMID: 15779234

Abstract

In the last few years, cardiac sympathetic dysfunction in Parkinson disease (PD) has been postulated on the basis of decreased cardiac uptake of sympathoneural imaging tracers. However, the pathological substrate for the dysfunction remains to be established. We examined the left ventricular anterior wall from postmortem specimens with immunohistochemical staining for tyrosine hydroxylase (TH), neurofilament (NF) and S‐100 protein in PD patients and control subjects, and quantified the immunoreactive areas. As TH‐immunoreactive axons nearly disappeared and NF‐immunoreactive axons drastically decreased in number, the morphological degeneration of the cardiac sympathetic nerves in PD was confirmed. Quantitative analysis showed that sympathetic nerves were preferentially involved. Triple immunofluorolabeling for NF, TH, and myelin basic protein showed clearly the profound involvement of sympathetic axons in PD. The extent of involvement of the cardiac sympathetic nerves seems likely to be equivalent to that in the central nervous system, including the nigrostriatal dopaminergic system. PD affects the cardiac sympathetic nervous system profoundly as well as nigrostriatal dopaminergic system.

Full Text

The Full Text of this article is available as a PDF (323.1 KB).

REFERENCES

  • 1. Chiueh CC, Zukowska‐Grojec Z, Kirk KL, Kopin IJ (1983) 6‐Fluorocatecholamines as false adrenergic neurotransmitters. J Pharmacol Exp Ther 225:529–533. [PubMed] [Google Scholar]
  • 2. Chow LT, Chow WH, Lee JC, Chow SS, Anderson RH, Gosling JA (1998) Postmortem changes in the immunohistochemical demonstration of nerves in human ventricular myocardium. J Anat 192:73–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Emery DG, Foreman RD, Coggeshall RE (1978) Categories of axons in the inferior cardiac nerve of the cat. J Comp Neurol 177:301–310. [DOI] [PubMed] [Google Scholar]
  • 4. Frank MB, Peter U, Nina S, Stephan GN, Bruno R, Markus S (2001) Myocardial Efficacy and Sympathetic Reinnervation After Orthotopic Heart Transplantation. Circulation 103:1881–1886. [DOI] [PubMed] [Google Scholar]
  • 5. Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST (2002) Orthostatic hypotension from sympathetic denervation in Parkinson's disease. Neurology 58:1247–1255. [DOI] [PubMed] [Google Scholar]
  • 6. Goldstein DS, Holmes C, Li ST, Bruse S, Metman LV, Cannon RO (2000) Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133:338–347. [DOI] [PubMed] [Google Scholar]
  • 7. Goto K, Longhurst PA, Cassis LA, Head RJ, Taylor DA, Rice PJ, Fleming WW (1985) Surgical sympathectomy of the heart in rodents and its effect on sensitivity to agonists. J Pharmacol Exp Ther 234:280–287. [PubMed] [Google Scholar]
  • 8. Haapaniemi TH, Pursiainen V, Korpelainen JT, Huikuri HV, Sotaniemi KA, Myllyl W (2001) Ambulatory ECG and analysis of heart rate variability in Parkinson's disease. J Neurol Neurosurg Psychiatry 70:305–310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Hardebo JE, Suzuki N, Ekblad E, Owman C (1992) Vasoactive intestinal polypeptide and acetylcholine coexist with neuropeptide Y, dopamine‐beta‐hydroxylase, tyrosine hydroxylase, substance P or calcitonin gene‐related peptide in neuronal subpopulations in cranial parasympathetic ganglia of rat. Cell Tissue Res 267:291–300. [DOI] [PubMed] [Google Scholar]
  • 10. Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihata M, Takahashi H (1999) Lewy body‐type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 52:1269–1271. [DOI] [PubMed] [Google Scholar]
  • 11. Kawano H, Okada R, Yano K (2003) Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 18:32–39. [DOI] [PubMed] [Google Scholar]
  • 12. Li ST, Dendi R, Holmes C, Goldstein DS (2002) Progressive loss of cardiac sympathetic innervation in Parkinson's disease. Ann Neurol 52:220–223. [DOI] [PubMed] [Google Scholar]
  • 13. Lloyd KG, Davidson L, Hornykiewicz O (1975) The neurochemistry of Parkinson's disease: effect of L‐dopa therapy. J Pharmacol Exp Ther 195:453–464. [PubMed] [Google Scholar]
  • 14. Maccarrone C, Jarrott B (1987) Differential effects of surgical sympathectomyon rat heart concentrations of neuropeptide Y‐immunoreactivity and noradrenaline. J Auton Nerv Syst 21:101–107. [DOI] [PubMed] [Google Scholar]
  • 15. Martins JB, Zipes DP (1980) Epicardial phenol interrupts refractory period responses to sympathetic but not vagal stimulation in canine left ventricular epicardium and endocardium. Circ Res 47:33–40. [DOI] [PubMed] [Google Scholar]
  • 16. McGeer PL, McGeer EG (1976) Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem 26:65–76. [PubMed] [Google Scholar]
  • 17. Mogi M, Harada M, Kiuchi K, Kojima K, Kondo T, Narabayashi H, Rausch D, Riederer P, Jellinger K, Nagatsu T (1988) Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain. J Neural Transm 72:77–82. [DOI] [PubMed] [Google Scholar]
  • 18. Molinoff PB, Axelrod J (1971) Biochemistry of catecholamines. Annu Rev Biochem 40:465–500. [DOI] [PubMed] [Google Scholar]
  • 19. Nagatsu T, Yamaguchi T, Rahman MK, Trocewicz J, Oka K, Hirata Y, Nagatsu I, Narabayashi H, Kondo T, Iizuka R (1984) Catecholamine‐related enzymes and the biopterin cofactor in Parkinson's disease and related extrapyramidal diseases. Adv Neurol 40:467–473. [PubMed] [Google Scholar]
  • 20. Nakamura A, Uchihara T (2004) Dual enhancement of triple immunofluorescence using two antibodies from the same species. J Neurosci Methods 135:67–70. [DOI] [PubMed] [Google Scholar]
  • 21. Neubauer B, Christensen NJ (1976) Norepinephrine, epinephrine, and dopamine contents of the cardiovascular system in long‐term diabetics. Diabetes 25:6–10. [DOI] [PubMed] [Google Scholar]
  • 22. Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K, Nagao T, Yokochi M (2002) Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy. J Neurol Neurosurg Psychiatry 73:776–777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Orimo S, Ozawa E, Nakade S, Hattori H, Tsuchiya K, Taki K, Takahashi A (2003)[123I] metaiodobenzylguanidine myocardial scintigraphy differentiates corticobasal degeneration from Parkinson's disease. Intern Med 42:127–128. [DOI] [PubMed] [Google Scholar]
  • 24. Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) 123I‐metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 67:189–194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Orimo S, Ozawa E, Oka T, Nakade S, Tsuchiya K, Yoshimoto M, Wakabayashi K, Takahashi H (2001) Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology 57:1140–1141. [DOI] [PubMed] [Google Scholar]
  • 26. Owman C (1988) Autonomic innervation of the cardiovascular system. In: Handbook of Chemical Neuroanatomy, Bjorklund A, Hokfelt T (eds.), Volume 6, The Peripheral Nervous System, Chapter IX, pp. 327–340, Elsevier: Amsterdam , New York , Oxford . [Google Scholar]
  • 27. Pardini BJ, Lund DD, Schmid PG (1990) Innervation patterns of the middle cervical‐stellate ganglion complex in the rat. Neurosci Lett 117:300–306. [DOI] [PubMed] [Google Scholar]
  • 28. Petch MC, Nayler WG (1979) Concentration of catecholamines in human cardiac muscle. Br Heart J 41:340–344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Reinhardt MJ, Jungling FD, Krause TM, Braune S (2000) Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine–123 MIBG uptake. Eur J Nucl Med 27:595–600. [DOI] [PubMed] [Google Scholar]
  • 30. Schuurman HJ, Plomp S, Wijngaard PL, Slootweg PJ, de Jonge N (1993) Innervation of the endomyocardium in the first period after heart transplantation. Transplantation 56:85–88. [DOI] [PubMed] [Google Scholar]
  • 31. Singh S, Johnson PI, Javed A, Gray TS, Lonchyna VA, Wurster RD (1999) Monoamine‐ and histamine‐synthesizing enzymes and neurotransmitters within neurons of adult human cardiac ganglia. Circulation 99:411–419. [DOI] [PubMed] [Google Scholar]
  • 32. Takahashi A (1991) Autonomic nervous system disorders in Parkinson's disease. Eur Neurol 31(Suppl 1):41–47. [DOI] [PubMed] [Google Scholar]
  • 33. Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M, Sakajiri K, Tonami N (2000) Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 27:566–573. [DOI] [PubMed] [Google Scholar]
  • 34. Uchihara T, Nakamura A, Nakayama H, Arima K, Ishizuka N, Mori H, Mizushima S (2003) Triple immunofluorolabeling with two rabbit polyclonal antibodies and a mouse monoclonal antibody allowing three‐dimensional analysis of cotton wool plaques in Alzheimer disease. J Histochem Cytochem 51:1201–1206. [DOI] [PubMed] [Google Scholar]
  • 35. van Stee EW (1978) Autonomic innervation of the heart. Environ Health Perspect 26:151–158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Wakabayashi K, Takahashi H (1997) Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 38 Suppl 2:2–7. [DOI] [PubMed] [Google Scholar]
  • 37. Wharton J, Polak JM, Gordon L, Banner NR, Springall DR, Rose M, Khagani A, Wallwork J, Yacoub MH (1990) Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res 66:900–912. [DOI] [PubMed] [Google Scholar]
  • 38. Wieland DM, Brown LE, Tobes MC, Rogers WL, Marsh DD, Mangner TJ, Swanson DP, Beierwaltes WH (1981) Imaging the primate adrenal medulla with [123I] and [131I] meta‐iodobenzylguanidine: concise communication. J Nucl Med 22:358–364. [PubMed] [Google Scholar]
  • 39. Yoshita M (1998) Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine–123–meta iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 155:60–67. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES